CN Stock MarketDetailed Quotes
002880 Shen Zhen Weiguang Biological Products
- 29.81
- -0.05-0.17%
Market Closed Dec 13 15:00 CST
6.76BMarket Cap27.03P/E (TTM)
30.46High29.75Low26.28KlotVolume30.46Open29.86Pre Close78.96MTurnover1.16%Turnover Ratio30.92P/E (Static)226.80MShares36.9752wk High3.16P/B6.74BFloat Cap21.8552wk Low32.85Limit Up226.02MShs Float50.78Historical High26.87Limit Down2.38%Amplitude14.47Historical Low0.20Dividend TTM30.05Avg Price11.60KlotAsk0.67%Div YieldTTM100Lot Size12.38KlotBid
Shen Zhen Weiguang Biological Products Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -3.18%780.45M | -8.23%539.73M | -6.66%223.74M | 72.30%1.17B | 132.49%806.06M | 92.27%588.1M | 34.20%239.71M | -27.31%678.47M | -44.22%346.7M | -19.32%305.87M |
| Refunds of taxes and levies | 58.55%21.02M | -92.88%944.45K | -99.16%87.45K | -77.41%10.33M | -67.12%13.26M | -65.02%13.26M | 11,083.04%10.42M | 360,509,962.41%45.75M | --40.32M | --37.9M |
| Cash received relating to other operating activities | -75.27%13.08M | -69.38%11.11M | -53.26%3.97M | 171.83%48.94M | 496.11%52.88M | 376.06%36.27M | 105.16%8.5M | -22.73%18.01M | -71.68%8.87M | -29.72%7.62M |
| Cash inflows from operating activities | -6.61%814.55M | -13.46%551.78M | -11.92%227.8M | 65.49%1.23B | 120.31%872.2M | 81.46%637.63M | 41.44%258.63M | -22.41%742.22M | -39.37%395.89M | -9.88%351.39M |
| Goods services cash paid | 8.11%395.41M | 4.46%247.52M | 8.36%116.52M | 11.78%491.32M | 37.84%365.76M | 18.10%236.96M | 19.07%107.54M | 1.58%439.53M | -17.40%265.34M | -0.57%200.64M |
| Staff behalf paid | 10.96%149.21M | 15.03%108.73M | 8.81%64.67M | 2.47%195.39M | 24.83%134.48M | -0.90%94.52M | 3.90%59.43M | 15.24%190.69M | -5.77%107.73M | 15.74%95.38M |
| All taxes paid | 15.93%84.33M | 14.27%55.67M | 18.24%29.52M | 33.04%82.48M | 51.01%72.75M | 22.60%48.72M | 5.29%24.96M | -12.89%62M | -10.25%48.17M | 23.41%39.74M |
| Cash paid relating to other operating activities | 1.49%84.61M | 84.71%63.58M | 86.88%28.81M | 25.28%61.14M | 131.30%83.36M | 14.72%34.42M | -9.39%15.42M | 20.75%48.8M | -16.80%36.04M | 2.83%30.01M |
| Cash outflows from operating activities | 8.72%713.57M | 14.68%475.51M | 15.52%239.52M | 12.05%830.34M | 43.53%656.35M | 13.36%414.63M | 10.15%207.35M | 4.41%741.02M | -14.14%457.29M | 5.84%365.77M |
| Net cash flows from operating activities | -53.22%100.98M | -65.80%76.27M | -122.85%-11.72M | 33,088.03%397.94M | 451.56%215.85M | 1,650.61%223M | 1,053.64%51.29M | -99.51%1.2M | -151.02%-61.4M | -132.42%-14.38M |
| Investing cash flow | ||||||||||
| Cash received from returns on investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.11M | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 343.69%131.62K | 327.58%126.84K | 1,455.31%126.84K | -37.16%73.39K | -21.94%29.66K | -21.94%29.66K | -78.54%8.16K | -49.23%116.8K | 10.79%38K | 222.03%38K |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20M | ---- | ---- |
| Cash inflows from investing activities | 343.69%131.62K | 327.58%126.84K | 1,455.31%126.84K | -99.65%73.39K | -21.94%29.66K | -21.94%29.66K | -78.54%8.16K | 9,124.35%21.22M | 10.79%38K | 222.03%38K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -8.50%198.77M | 42.85%148.17M | -38.07%46.47M | 0.45%328.85M | 19.61%217.24M | -33.58%103.72M | 32.87%75.04M | 35.94%327.37M | 7.68%181.63M | 127.39%156.16M |
| Cash paid to acquire investments | 300.00%4M | 300.00%4M | ---- | --1M | --1M | --1M | ---- | ---- | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --22.39M | --6.84M | --6.84M | --6.84M | ---- | ---- | ---- |
| Cash paid relating to other investing activities | 1,283.12%97.75K | ---- | ---- | ---- | --7.07K | ---- | ---- | --181.11M | ---- | ---- |
| Cash outflows from investing activities | -9.87%202.87M | 36.40%152.17M | -43.24%46.47M | -30.73%352.24M | 23.93%225.09M | -28.56%111.56M | 44.98%81.88M | 75.15%508.48M | -14.79%181.63M | 58.26%156.16M |
| Net cash flows from investing activities | 9.92%-202.74M | -36.32%-152.04M | 43.39%-46.35M | 27.73%-352.17M | -23.94%-225.06M | 28.56%-111.53M | -45.06%-81.87M | -67.98%-487.26M | 14.79%-181.59M | -58.24%-156.12M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -12.50%3.5M | --3.5M | --3.5M |
| Cash from borrowing | 96.95%243.02M | 249.24%215.36M | 190.74%154.38M | -65.95%179.97M | -70.71%123.39M | -84.91%61.67M | -70.50%53.1M | 604.64%528.48M | 461.73%421.29M | 1,943.20%408.64M |
| Cash inflows from financing activities | 96.95%243.02M | 249.24%215.36M | 190.74%154.38M | -66.17%179.97M | -70.95%123.39M | -85.04%61.67M | -71.06%53.1M | 573.39%531.98M | 466.39%424.79M | 1,960.70%412.14M |
| Borrowing repayment | -67.10%65.8M | -35.20%64.8M | --6.13M | 704.50%201.13M | 700.00%200M | 400.00%100M | --0 | -81.06%25M | -81.06%25M | -75.61%20M |
| Dividend interest payment | 289.57%60.38M | -4.97%10.53M | -6.04%5.11M | 13.72%65.6M | 241.82%15.5M | 243.26%11.08M | 501.92%5.44M | 37.93%57.68M | -89.09%4.53M | -92.13%3.23M |
| Cash payments relating to other financing activities | 1,046.67%10.73M | 1,586.67%10.52M | -57.10%207.9K | 2.14%1.42M | 7.44%935.55K | -18.66%623.7K | 3.16%484.65K | 2.79%1.39M | --870.75K | --766.8K |
| Cash outflows from financing activities | -36.75%136.9M | -23.15%85.85M | 93.10%11.45M | 218.94%268.15M | 611.84%216.43M | 365.53%111.7M | -72.26%5.93M | -52.01%84.08M | -82.48%30.4M | -80.49%23.99M |
| Net cash flows from financing activities | 214.06%106.12M | 358.83%129.52M | 203.02%142.93M | -119.69%-88.18M | -123.59%-93.04M | -112.89%-50.04M | -70.91%47.17M | 565.72%447.9M | 500.10%394.39M | 476.77%388.14M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 104.27%4.36M | -12.51%53.75M | 411.67%84.87M | -11.14%-42.41M | -167.54%-102.25M | -71.77%61.43M | -83.46%16.59M | 72.62%-38.16M | 179.11%151.4M | 238.34%217.65M |
| Add:Begin period cash and cash equivalents | -14.62%251.45M | -14.62%251.45M | -14.61%251.48M | -11.49%293.85M | -11.33%294.49M | -11.33%294.49M | -11.33%294.49M | -29.57%332.01M | -29.55%332.1M | -27.14%332.1M |
| End period cash equivalent | 33.07%255.81M | -14.25%305.19M | 8.12%336.34M | -14.43%251.44M | -60.24%192.24M | -35.26%355.92M | -28.06%311.08M | -11.49%293.85M | 72.67%483.5M | 84.16%549.75M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
